Brief: Geron says FDA Accepts Of New Drug Application For The Treatment Of Lower Risk Mds

Geron

21/08/2023 13:07

Aug 21 (Reuters) - 
  
    * GERON ANNOUNCES FDA ACCEPTANCE OF NEW DRUG APPLICATION FOR
IMETELSTAT FOR THE TREATMENT OF LOWER RISK MDS
    * GERON CORP - EXPECTS TO SUBMIT A MARKETING AUTHORIZATION
APPLICATION (MAA) IN EUROPEAN UNION (EU) IN Q4 OF 2023
    * GERON CORP -  UPON RECEIPT OF PDUFA FOR NDA, GERON PLANS
TO
DISCLOSE TIMELINE FOR NDA REVIEW

Source text for Eikon:  ID:nBw1fKxCxa 
Further company coverage:  GERN.O 

 ((Reuters.Briefs@thomsonreuters.com;))